NanoGroup S.A. Logo

NanoGroup S.A.

Develops patented nanotechnology for oncology and transplantology diagnostics and therapies.

NNG | WAR

Overview

Corporate Details

ISIN(s):
PLNNGRP00011 (+3 more)
LEI:
259400HXWEAZUWRLY648
Country:
Poland
Address:
Warszawa Rakowiecka 36, 02-532 Warszawa
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NanoGroup S.A. is a biotechnology company that develops and commercializes innovative medical solutions based on its unique, patented nanotechnology. The group's research and development work is concentrated on addressing critical medical needs, primarily in the fields of oncology and transplantology. Key projects include the development of nanoformulations for anticancer drugs, a fluid for the storage of organs intended for transplantation, nanoparticles for diagnostics and therapy, and a human blood substitute. The company operates through specialized subsidiaries, such as nanoSanguis and nanoVelos, to advance its distinct technological platforms and bring new medical technologies to market.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-06 16:58
Board/Management Information
Oświadczenie
Polish 156.9 KB
2025-10-06 16:58
Board/Management Information
Życiorys
Polish 324.7 KB
2025-10-06 16:58
Board/Management Information
Zgłoszenie kandydata na Członka Rady Nadzorczej NANOGROUP S.A. - Content (PL)
Polish 766 bytes
2025-10-06 12:47
Board/Management Information
Oświadczenie
Polish 131.2 KB
2025-10-06 12:47
Board/Management Information
Życiorys
English 199.3 KB
2025-10-06 12:47
Board/Management Information
Zgłoszenie kandydata na Członka Rady Nadzorczej NANOGROUP S.A. - Content (PL)
Polish 780 bytes
2025-10-01 17:02
Related Party Transaction
Powiadomienie
Polish 4.4 KB
2025-10-01 17:02
Major Shareholding Notification
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
Polish 545 bytes
2025-10-01 16:53
Director's Dealing
Powiadomienie
Polish 4.3 KB
2025-10-01 16:53
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
Polish 469 bytes
2025-09-25 18:33
Audit Report / Information
Raport audytora
Polish 647.6 KB
2025-09-25 18:33
Interim Report
Sprawozdanie
Polish 1.1 MB
2025-09-25 18:23
Audit Report / Information
Opinia Rady Nadzorczej
Polish 56.6 KB
2025-09-25 18:23
Management Discussion and Analysis
Stanowisko Zarządu
Polish 325.8 KB
2025-09-25 18:23
Audit Report / Information
Raport audytora
Polish 636.8 KB

Automate Your Workflow. Get a real-time feed of all NanoGroup S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NanoGroup S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AnGes, Inc. Logo
Develops gene-based medicines like HGF gene therapy, DNA vaccines, and NF-kB decoys.
Japan 4563
ANIMALCARE GROUP PLC Logo
Develops & sells veterinary prescription & OTC medicines for professionals worldwide.
United Kingdom ANCR
Annexin Pharmaceuticals AB Logo
Developing Annexin A5 protein to treat vascular, inflammatory, and cancerous diseases.
Sweden ANNX
ANTEROGEN CO., LTD. Logo
Develops and commercializes adult stem cell therapies and orphan drugs for medical conditions.
South Korea 065660
Antibiotice S.A. Logo
Develops and manufactures generic medicines and APIs, specializing in anti-infectives.
Romania ATB
Apontis Pharma AG Logo
German pharma firm specializing in Single Pills for cardiovascular and chronic diseases.
Germany APPH
AprilBio Co.,Ltd. Logo
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
South Korea 397030
Aprogen Biologics Inc. Logo
Develops and manufactures novel biologic drugs and biosimilars for the professional market.
South Korea 003060
Aprogen, Inc Logo
Develops and manufactures novel biologics and biosimilars for cancer and arthritis treatments.
South Korea 007460
Develops drugs for fibrosis, inflammation, and cancer using NOX inhibitor & CAF modulation tech.
South Korea 293780

Talk to a Data Expert

Have a question? We'll get back to you promptly.